Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 2,201–2,300 of 2,883
Searching for a Cancer-Proof Organism: It’s the Journey That Teaches You About the Destination
Kokko, H., Schindler, S., & Sprouffske, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00022-3 · Cited by 3
Platelet Immune Interactions, Lifespan, and Senescence
Nydegger, U. E., & Imbach, P. A. (2025) · OBM Geriatrics · doi:10.21926/obm.geriatr.2501297 · Cited by 2
Tsolova, A. O., Lea, G., Jadli, A. S., Mastrokolias, A., Narang, A., Krala, A., Radford, B. N., Hanna, C. W., Kelsey, G., Critchley, H., et al. (2025) · NAR Molecular Medicine · doi:10.1093/narmme/ugaf031 · Cited by 3
Li, Y., Li, C., Zhou, Q. X., Liu, X., Qiao, Y., Xie, T., Sun, H., Ong, M. T., & Wang, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599817 · Cited by 2
Sedrak, M. S., Knecht, A. K., Strum, S. L., Sun, C., Ding, Y. C., Ji, J., White, T. A., Nyrop, K. A., LeBrasseur, N. K., Neuhausen, S. L., et al. (2023) · medRxiv · doi:10.1101/2023.05.06.23289535 · Cited by 3
Zhu, Z., Li, L., Ye, Y., & Zhong, Q. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00996-w · Cited by 3
Neurotropic Viruses as Acute and Insidious Drivers of Aging
Rocchi, A. R., Wollebo, H. S., & Khalili, K. (2025) · Biomolecules · doi:10.3390/biom15040514 · Cited by 2
“Senescence has been demonstrated to cause organism aging and lifespan in vivo [147].”
Can hypoxic exercise retard cellular senescence? A narrative review
Huang, T., Tsang, C. S. L., & Huang, T. (2024) · European Review of Aging and Physical Activity · doi:10.1186/s11556-024-00352-9 · Cited by 4
Is ageing a disease? The debate that could reshape medicine
Nuwer, R. (2025) · Nature · doi:10.1038/d41586-025-03525-3 · Cited by 2
Cellular senescence during aging and chronic liver diseases
Jurk, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00005-5 · Cited by 2
Aging as a multifactorial disorder with two stages
Gems, D., Carver, A., & Zhao, Y. (2025) · Aging · doi:10.18632/aging.206339 · Cited by 3
“…(geroconversion), becoming hypertrophic and hyper-secretory, exhibiting the senescence-associated secretory phenotype (SASP), which promotes development of tumors (Coppé et al., 2010) and, as suggested by murine studies, many other senescent pathologies (Baker et al., 2016; Childs et al., 2016).”
Παπανικολάου, Κ., Yadav, A., Mankowski, R. T., Alexander, M. S., Gamboa, J. L., Thalacker‐Mercer, A. E., Dungan, C. M., & Englund, D. A. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00876.2025 · Cited by 2
Senotherapy: Implications for Transplantation
Jaros, M., & Melk, A. (2025) · Transplantation · doi:10.1097/tp.0000000000005291 · Cited by 3
Zhang, Z., Zhu, S., Li, Q., Wei, S., Li, Y., Zhu, J., Yang, S., Zhang, W., & Lai, K. (2025) · Lupus · doi:10.1177/09612033251317783 · Cited by 3
Dan, K., Takada, A., Kanaho, Y., Kusumi, Y., & Banno, H. (2020) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v10i6.671 · Cited by 3
31. Trade-Offs between Mortality Components in Life History Evolution: The Case of Cancers
Pavard, S., & Metcalf, C. J. E. (2024) · Open Book Publishers · doi:10.11647/obp.0251.31 · Cited by 5
Mechanisms of cell senescence in aging
von Zglinicki, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00003-2 · Cited by 3
Communication breakdown: senescent cells in interorgan communication of aging
Ghosh, R. B., Dipali, S. S., Desdín-Micó, G., & Yousefzadeh, M. J. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.02.002 · Cited by 5
Senescence-Accelerated Mice Prone 8 (SAMP8) in male as a spontaneous osteoarthritis modelPreprint
Sanada, Y., Ikuta, Y., Ding, C., Shinohara, M., Yimiti, D., Ishitobi, H., Nagira, K., Lee, M., Akimoto, T., Shibata, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1665184/v1 · Cited by 2
Mitochondrial Dysfunction in Renal Aging: A Vicious Cycle Driving Kidney Disease Progression
Yu, W., Ouyang, Q., Liu, W., Jia, L., & Wang, B. (2026) · Antioxidants and Redox Signaling · doi:10.1177/15230864251410936 · Cited by 4
“Glomerulosclerosis signi fi - cantly increased between 12 and 18 months in vehicle-treated ATTAC mice, indicating age-related functional impairment in the kidney (Baker et al., 2016).”
Cellular senescence in cancers: relationship between bone marrow cancer and cellular senescence
Sarikhani, M., & Firouzamandi, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07101-6 · Cited by 2
Redox metabolism in cell senescence: focusing on contributions from the metabolomic field
Chacón, E., Grünwaldt, G., Marmisolle, I., Martínez, J., & Quijano, C. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1754469 · Cited by 2
“In other contexts, however, the accumulation of non-proliferating senescent cells and prolonged SASP exposure have detrimental effects, being associated with chronic inflammation, tissue dysfunction, and active contribution to the ageing process (Baker et al., 2011; Baker et al., 2016).”
Les horloges de la longévité: Le rôle promoteur des télomères ?
Cherfils‐Vicini, J., & Gilson, É. (2020) · médecine/sciences · doi:10.1051/medsci/2020242 · Cited by 3
Bases moléculaires du vieillissement rénal
Cohen, C. (2021) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2020.02.006 · Cited by 3
Martínez‐Zamudio, R. I., & Herbig, U. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_38-1 · Cited by 2
Fathi, E., Montazersaheb, S., Sanaat, Z., Nakhlband, A., Vandghanooni, S., Farahzadi, R., & Vietor, I. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220511141123 · Cited by 2
Game changer: Navigating between challenges and hopes in geropharmacology
Chen, Q., Hartman, R., Dankiv, L., Yan, E., Young, L. H., & Barsotti, R. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.02.007 · Cited by 2
Yan, L., Zheng, J., Lu, Z., Zhu, A., Ye, M., Meng, J., Tang, J., & Zhang, H. (2026) · Circulation · doi:10.1161/circulationaha.125.077172 · Cited by 4
PCBP2 Regulates p16 INK4a ‐Dependent Cellular Senescence in Response to Iron
Yan, S., Lu, L., Wu, Y., Du, Z., Johny, E., Dutta, P., & Li, G. (2025) · Aging Cell · doi:10.1111/acel.70283 · Cited by 2
“This is because genetic or pharmacological depletion of p16 INK4a - positive cells in various mouse models delays the onset of age-related diseases and extends the lifespan (Baker et al. 2011, 2016; Dang et al. 2020; Hickson et al. 2019).”
Senescence and Cellular Immortality
Demaria, M., & Velarde, M. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65016-x · Cited by 2
Gurkar, A. U., Gill, M. S., & Niedernhofer, L. J. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-44703-2_11 · Cited by 2
Extracellular Vesicles and Cardiac Aging
Seara, F. D. A. C., Maciel, L., Kasai-Brunswick, T. H., Nascimento, J. H. M., & de Carvalho, A. C. C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_3 · Cited by 2
Induction and Characterization of Cellular Senescence in Salamanders
Yu, Q., Walters, H., & Yun, M. H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2659-7_8 · Cited by 2
Cellular Reprogramming and Aging
Pereira, S. N., & de Jesus, B. B. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-43939-2_5 · Cited by 2
An Indocyanine Green‐Based Nanoprobe for In Vivo Detection of Cellular Senescence
Baker, A. G., Hartono, M., Ou, H., Bistrović, A., Brown, E. L., Joseph, J., Golinska, M. A., González‐Gualda, E., Macías, D., Ge, J., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202404885 · Cited by 2
Senescent cell heterogeneity: origins, detection, and therapeutic implications
Wu, R., Zhu, J., Kim, H., & Xu, M. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.03.015 · Cited by 7
Castro, C., Delwarde, C., Shi, Y., & Roh, J. D. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.15 · Cited by 3
“In the aging heart, senescent cardiomyocytes produce a SASP profile that contributes to age-associated cardiac hypertrophy, fibrosis, systolic and diastolic dysfunction, and loss of regenerative potential [28,75,78] .”
The Role of p16Ink4a as an Early Predictor of Physiological Decline during Natural AgingPreprint
Tang, L., Hladyshau, S., Ross, A., Nyrop, K. A., Entwistle, A., Muss, H. B., Mitin, N., & Tsygankov, D. (2024) · medRxiv · doi:10.1101/2024.11.21.24317752 · Cited by 2
“Injected and naturally occurring p16-positive cells have been shown to induce disease and shorten the healthy lifespan, while depleting p16-positive cells improves physical function and delays aging-associated disorders [5, 6, 12, 24, 25].”
Zhang, B., Yan, P., Li, Z., Xiong, J., Geng, Z., Wei, W., Zhang, Y., Wu, G., Zhuang, T., Tian, X. Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-275582/v1 · Cited by 2
Neherin, K., Holloway, K., Song, Y., Houston, A., Chen, F., Ding, L., & Zhang, H. (2026) · Advanced Biology · doi:10.1002/adbi.202500468 · Cited by 3
Bmi‐1 alleviates alveolar bone resorption through the regulation of autophagy
Chu, Y., Liu, S., Yan, L., & Gong, A. (2024) · Journal of Periodontology · doi:10.1002/jper.23-0796 · Cited by 2
Sugiyama, Y., Kawabe, Y., Harada, T., Aoki, Y., Tsuji, K., Sugiyama, D., & Maruyama, M. (2024) · Genes to Cells · doi:10.1111/gtc.13163 · Cited by 2
“Now-adays, several types of senescent cells-removable mice, known as senolytic model, have been reported and these models clarified that the clearance of senescent cells in vivo attenuated age-related disorders and promoted a healthy lifespan (Baker et al., 2011, 2016; Hashimoto et al., 2016).”
Endothelial cell senescence — understanding aging and disease
Coleman, P. R., Ting, K. K., Qi, Y., Vadas, M. A., & Gamble, J. R. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100702 · Cited by 3
Genetic architecture of human aging and longevity: Insights from genome-wide association studies
Yoon, D., & Gim, J. (2026) · BMB Reports · doi:10.5483/bmbrep.2025-0226 · Cited by 4
Understanding cardiac senescence one cell type at a time
Sen, P., & Gurha, P. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.16 · Cited by 2
“Elimination of p16-positive senescent cells by a drug-inducible “suicide” gene was shown to improve health and lifespan in both progeroid and naturally aged mice[11,12].”
BackgroundWhy stem/progenitor cells lose their regenerative potential
Picerno, A., Stasi, A., Franzin, R., Curci, C., di Bari, I., Gesualdo, L., & Sallustio, F. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i11.1717 · Cited by 7
The Aging Microenvironment in Lung Fibrosis
Deinhardt‐Emmer, S., & Saux, C. J. L. (2022) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-022-00038-3 · Cited by 3
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
Vardon, A., Haston, S., Hamdi, H., Cooksley, G., Guiho, R., Carvalho, D. M., Carter, R., Boult, J. K. R., Gharai, D., Cloete, I., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32676-6 · Cited by 4
Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies
Lin, X., Wu, Z., Liu, Y., & Liao, X. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1668623 · Cited by 3
Song, C., Liu, W. L., Jiang, G., Zhao, H., Wang, R., Wang, X., Chen, R., Mao, W., & Zhu, S. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152751 · Cited by 2
Spurious transcription may be a hallmark of aging
Isima, N., & Gil, J. (2023) · Nature Aging · doi:10.1038/s43587-023-00398-x · Cited by 3
To Find and Destroy: Identification and Elimination of Senescent Cells
Borodkina, A. V., Deryabin, P. I., Griukova, A., & Nikolsky, N. N. (2018) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818030030 · Cited by 3
Furuta, R., Urate, S., Wakui, H., Uehara, T., Tsukamoto, S., Taguchi, S., Morita, R., Okami, N., Yamashita, A., Azushima, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-08642-7 · Cited by 3
Huo, L., Zhang, H., Tang, C., Cui, G., Xue, T., Guo, H., Yao, F., Zhang, W., & Feng, W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04503-y · Cited by 2
Cavinato, M. S., Wedel, S., & Jansen‐Dürr, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11409-6 · Cited by 3
Senescence of endplate osteoclasts induces sensory innervation and spinal painPreprint
Pan, D., Benkato, K. G., Han, X., Zheng, J., Kumar, V., Wan, M., Zheng, J., & Cao, X. (2023) · eLife · doi:10.7554/elife.92889.1 · Cited by 2
Cantero‐Fortiz, Y., Butler, C., Montalbán, X., & Boada, M. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1805691 · Cited by 9
“Most currently used biomarkers lack specificity and may reflect overlapping biological processes such as inflammation, activation, or cellular stress (Suryadevara et al., 2024; Suryadevara et al., 2024; McCullumsmith et al., 2014; Baker et al., 2016).”
The role of exercise in bolstering cardiac resilience during aging
Saini, A. S., Foote, K., Bennett, M. R., & Vujić, A. (2025) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.18 · Cited by 2
A Platinum‐Aluminum Bimetallic Salen Complex for Pro‐senescence Cancer Therapy
Tang, J., Yang, Y., Yin, H., Ma, B., Zhu, M., Yang, Z., Peng, X., Jia, F., Zhao, Y., Wang, F., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202400105 · Cited by 2
Rinnerthaler, M., & Richter, K. (2018) · InTech eBooks · doi:10.5772/intechopen.76246 · Cited by 3
A sirtuin's role in preventing senescence by protecting ribosomal DNA
Etchegaray, J., & Mostoslavsky, R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.h118.004040 · Cited by 2
Cellular senescence and senotherapeutics in cardiovascular diseases
Pal, A. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.019 · Cited by 2
Tracking senescent cells: A new biomarker assay opens new avenues in senescence research
Bujarrabal-Dueso, A., & Schumacher, B. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.01.009 · Cited by 2
The double-edged sword of eliminating senescent cells
Gilson, É. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00798-w · Cited by 2
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis
Czaja, A. J. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2432480 · Cited by 2
Noncanonical Cell Death Induction by Reassortant Reovirus
Stewart, R. M. R., Raghuram, V., Berry, J. T. L., Joshi, G. N., & Mainou, B. A. (2020) · Journal of Virology · doi:10.1128/jvi.01613-20 · Cited by 3
Of Barriers and Loops—How Evolution Limits Most Cancer Risks to Older Ages
Dominici, M. D., & DeGregori, J. V. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0779 · Cited by 4
Sun, W., Wu, T., Zhou, Z., Jiang, D., Wei, T. W., Han, S. Y., Shyy, J., Li, G., & Shi, R. (2025) · Research Square · doi:10.21203/rs.3.rs-6999919/v1 · Cited by 2
“The accumulation of p16 INK4a -positive cells is linked to aging-related organ dysfunction, and the clearance of these maladapted cells delays the onset of age-related diseases and extends the lifespan in mice 19,20 .”
Konopko, A., Sęktas, K., Targońska, A., Amorati, R., Bielak-Żmijewska, A., & Litwinienko, G. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119357 · Cited by 2
Perspectives to Modify and Counter Aging in the Frame of Subtelomere–Telomere Theory of Aging
Libertini, G. (2022) · OBM Geriatrics · doi:10.21926/obm.geriatr.2204208 · Cited by 2
Senolytics Target Senescent Cells and Improve Aging and Age-Related Diseases
Buffard, T., & Ferbeyre, G. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_4 · Cited by 4
Yang, C., Xu, Z., He, S.-T., Zheng, G.-J., Wang, J., Zang, F., Hu, J.-Q., Wang, Y., Zhang, W.-Y., Gao, C.-F., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01124-z · Cited by 4
“Consistent with previous studies reporting only mild histopathological changes 57,58 , key SASP factors such as TNF and IL-6 are not significantly increased in naturally aged mouse discs 59 , whereas many other tissues show clear age-related deterioration from around 12 months 60 .”
Exploration of New Therapies for Heart Failure Targeting Age-Related Mechanisms
Shimizu, I. (2023) · Circulation Journal · doi:10.1253/circj.cj-23-0419 · Cited by 2
Amiri, F., & Mistriotis, P. (2024) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-024-00807-0 · Cited by 2
Madonna, R. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.34 · Cited by 2
Bi, J., Zeng, J., Liu, X., Mo, C., Yao, M., Zhang, J., Yuan, P., Jia, B., & Xu, S. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102209 · Cited by 2
Kawamoto, S., Horiguchi, H., Torigoe, D., Wakita, M., Ito, K., Sugawara, S., Zhou, X., Mikawa, T., Park, J. H., Jung, B. K., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00740-5 · Cited by 3
“Using this model, they genetically demonstrated that the ablation of p16 INK4a - expressing cells reduced the incidence of aging-associated cancers and extended health span (Baker et al, 2016).”
Iranpour, M., Dabiri, S., Rezazade, M., & Bagheri, F. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2021.104280.2095 · Cited by 2
(2019) · doi:10.1101/684811 · Cited by 4
Conclusive Identification of Senescent T Cells Reveals Their Abundance in Aging Humans
(2020) · doi:10.1101/2020.06.17.157826 · Cited by 213
Molecular biology, genetic, and epigenetics of bladder tumor
Inanloo, S. H., Aghamir, S. M. K., Bahri, R. A., Ghajar, H. A., & Karimian, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-27302-5.00006-1 · Cited by 4
Senotypes define the diverse landscape of senescent cells
Schafer, M. J., Basisty, N., Hertzel, A. V., Rindone, A. N., Elisseeff, J. H., Suryadevara, V., Aliferis, C., Robbins, P. D., Niedernhofer, L. J., Miller, K. N., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01148-5 · Cited by 8
“In young mice, clearance of p16 + cells in p16-3MR 8 and INK-ATTAC 57 mice delayed wound healing, suggesting a beneficial role in the healing process.”
Self-citationMou, J., Zhou, H., Shen, W., & Zhu, L. (2025) · Dyes and Pigments · doi:10.1016/j.dyepig.2025.113487 · Cited by 2
Polyploidy in Liver Function, Mitochondrial Metabolism, and Cancer
Delgado, E. R., Stahl, E. C., Roy, N., Wilkinson, P. D., & Duncan, A. W. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch47 · Cited by 2
Nguyen, D. T., Prieto, L. I., Zhang, C., Li, H., Khoór, A., Weems, C. R., Jamieson, L., Jeganathan, K. B., Babu, S. R., Murray, N. R., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116606 · Cited by 2
“42 Our orthotopic tumor models allowed unequivocal targeting of senescent KP and KPI tumor cells for INK-ATTAC, thus eliminating the potential complication of loss of other sensitive cell types and allowing us to identify a direct relationship between the emergence of senescent PATS-like cells and…”
Self-citationMallikarjun, V., Dobre, O., Jackson, M. R., Kidd, M., Llewellyn, J., Gilbert, H. T. J., Richardson, S. M., & Swift, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.09.511462 · Cited by 3
Nucleosome disruption by 5‐bromodeoxyuridine leads to senescence
Guerrero, A. (2022) · FEBS Journal · doi:10.1111/febs.16630 · Cited by 2
Yang, S. S., Chen, Y., Liu, S. R., Zuo, A., Ba, Y., Zhang, Y., Liu, B., Zhang, C., Xu, H., Luo, P., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-4870 · Cited by 5
Interconnection Between Cellular Senescence, Regeneration and Ageing in Salamanders
Yu, Q., & Yun, M. H. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_3 · Cited by 3
Takaya, K., Asou, T., & Kishi, K. (2023) · Rejuvenation Research · doi:10.1089/rej.2023.0020 · Cited by 2
The Role of Sirtuins in Cellular Senescence and the Development of Age-Associated Diseases
Markelov, V. A., Akhmadishina, L. Z., Кочетова, О. В., Эрдман, В. В., & Korytina, G. F. (2025) · Russian Journal of Genetics · doi:10.1134/s1022795425700152 · Cited by 1
Majeed, Y., Halabi, N. M., Engelke, R., Sarwath, H., Al-Noubi, M. N., Choi, S., Al-Malki, A., Agha, M. V., Vakayil, M., Chouchane, L., et al. (2025) · eLife · doi:10.7554/elife.109214.1 · Cited by 1
Impact of Cellular Senescence on Cellular Clocks
Nakahata, Y. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-22468-3_5 · Cited by 1
Wang, R., Chen, Y., Yin, X., Wang, X., Zan, J., & Zhang, Y. (2026) · Heart & Lung · doi:10.1016/j.hrtlng.2026.102824 · Cited by 1
Taliaferro, L. P., Buchsbaum, J. C., DiCarlo, A. L., Dixon, C. A., Macchiarini, F., Satyamitra, M. M., PrabhuDas, M., & Rudokas, M. W. (2025) · Radiation Research · doi:10.1667/rade-24-00263.1 · Cited by 1
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.